{{Drugbox
| Watchedfields = changed
| verifiedrevid = 462267348
| IUPAC_name = 2-diethylaminoethyl 4-amino-3-butoxy-benzoate
| image = Oxybuprocaine.svg
<!--Clinical data-->
| tradename = Novesin(e)
| Drugs.com = {{drugs.com|international|oxybuprocaine}}
| pregnancy_AU = D
| legal_status = 
| routes_of_administration = Topical
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = [[Esterase]]s in blood plasma and liver
| elimination_half-life = 
<!--Identifiers-->
| IUPHAR_ligand = 7123
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 99-43-4
| ATC_prefix = D04
| ATC_suffix = AB03
| ATC_supplemental =  {{ATC|S01|HA02}}
| PubChem = 4633
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00892
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4472
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = AXQ0JYM303
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08319
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 309594
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1200
<!--Chemical data-->
| C=17 | H=28 | N=2 | O=3
| molecular_weight =  308.41 g/mol
| smiles = O=C(OCCN(CC)CC)c1cc(OCCCC)c(cc1)N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H28N2O3/c1-4-7-11-21-16-13-14(8-9-15(16)18)17(20)22-12-10-19(5-2)6-3/h8-9,13H,4-7,10-12,18H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = CMHHMUWAYWTMGS-UHFFFAOYSA-N
}}
'''Oxybuprocaine''' ([[International Nonproprietary Name|INN]]), also known as '''benoxinate''' or '''BNX''', is an ester-type [[local anesthetic]], which is used especially in [[ophthalmology]] and [[otolaryngology]]. Oxybuprocaine is sold by [[Novartis]] under the brand names '''Novesine''' or '''Novesin'''.

Safety for use in pregnancy and lactation has not been established.

== Uses ==
* In [[ophthalmology]] in order to numb the surface of the [[human eye|eye]] (the outermost layers of the [[cornea]] and [[conjunctiva]]) for the following purposes:<ref name="Drugs.com">Drugs.com: [http://www.drugs.com/uk/minims-oxybuprocaine-hydrochloride-0-4-917.html Minims Oxybuprocaine Hydrochloride 0.4%]</ref>
** in order to perform a [[tonometry|contact/applanation tonometry]],
** for small operations,
** in order to remove small foreign objects from the uppermost layer of the cornea or conjunctiva;
* in [[otolaryngology]] for numbing the [[mucous membrane]]s of the [[nostrils]] and [[pharynx]], for diagnostic purposes and small operations,<ref name="AustriaCodex">{{cite book|title=Austria-Codex|editor=Jasek, W|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2007|edition=2007/2008|isbn=978-3-85200-181-4|language=German}}</ref>
* for numbing the mucous membranes of [[bronchi]], for example in [[bronchoscopy]],<ref name="AustriaCodex" />
* and the [[oesophagus]], for example in [[intubation]].<ref name="AustriaCodex" />

== Pharmacokinetics ==
Anaesthesia starts with a latency of 30 to 50 seconds and lasts for about 10 to 30 minutes, depending on [[perfusion]]. The drug is metabolised by [[esterase]]s in blood plasma and liver.<ref name="AustriaCodex" />

== Adverse effects ==
When used excessively, oxybuprocaine like any other topical anesthetic used in the eye and on mucous membranes (like for example [[tetracaine]], [[proxymetacaine]] and [[proparacaine]]) can cause irritation, [[hypersensitivity]], [[anaphylaxis]], irreversible corneal damage and even complete destruction of the cornea.<ref name="Drugs.com" /><ref>{{Cite journal | last1 = McGee | first1 = H. T. | last2 = Fraunfelder | first2 = F. W. | doi = 10.1517/14740338.6.6.637 | title = Toxicities of topical ophthalmic anesthetics | journal = Expert Opinion on Drug Safety | volume = 6 | issue = 6 | pages = 637–640 | year = 2007 | pmid = 17967152 | pmc = }}</ref> (Excessive use means several times a day during several days or even weeks.)

== Interactions ==
Oxybuprocaine is incompatible with [[silver]] and [[mercury (element)|mercury]] salts, as well as [[Base (chemistry)|basic substances]]. It also reduces the antimicrobial action of [[sulfonamide (medicine)|sulfonamide]]s.<ref name="AustriaCodex" />

==See also==
*[[Topical anesthetic]]

==References==
{{reflist}}

{{Antipruritics}}

[[Category:Otorhinolaryngology]]
[[Category:Local anesthetics]]
[[Category:Benzoates]]
[[Category:Anilines]]
[[Category:Phenol ethers]]